Predictive Oncology Stock Momentum Indicators Chande Momentum Oscillator
| POAI Stock | USD 0.80 0.05 6.67% |
| Symbol |
Illegal number of arguments. The output start index for this execution was zero with a total number of output elements of zero. The Chande Momentum Oscillator (CMO) is a technical momentum indicator created by Tushar Chande. Predictive Oncology CMO bullish signals are generated when the oscillator goes above the signal, and bearish signals are generated when Predictive Oncology oscillator crosses down through the signal.
Predictive Oncology Technical Analysis Modules
Most technical analysis of Predictive Oncology help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Predictive from various momentum indicators to cycle indicators. When you analyze Predictive charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Predictive Oncology Predictive Technical Analysis
Predictive technical analysis modules help investors to analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Predictive Oncology. We use our internally-developed statistical techniques to arrive at the intrinsic value of Predictive Oncology based on widely used predictive technical indicators. In general, we focus on analyzing Predictive Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Predictive Oncology's daily price indicators and compare them against related drivers, such as momentum indicators and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of Predictive Oncology's intrinsic value. In addition to deriving basic predictive indicators for Predictive Oncology, we also check how macroeconomic factors affect Predictive Oncology price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
| 2021 | 2022 | 2024 (projected) | Payables Turnover | 0.48 | 0.54 | 0.31 | Days Of Inventory On Hand | 290.55 | 311.08 | 387.01 |
Align your values with your investing style
In addition to having Predictive Oncology in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Thematic Opportunities
Explore Investment Opportunities
Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Casinos Invested over 90 shares | |
 | Macroaxis Index Invested few shares | |
 | Momentum Invested over 60 shares | |
 | Impulse Invested over 100 shares | |
 | Banking Invested over 20 shares | |
 | Hedge Favorites Invested over 40 shares | |
 | SRI Sustainable Growth Invested few shares | |
 | Adviser Favorites Invested few shares | |
 | Manufacturing Invested over 30 shares | |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Predictive Oncology. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. For more detail on how to invest in Predictive Stock please use our How to Invest in Predictive Oncology guide.You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Predictive Oncology. If investors know Predictive will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Predictive Oncology listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.96) | Revenue Per Share 0.416 | Quarterly Revenue Growth (0.43) | Return On Assets (0.56) | Return On Equity (1.49) |
The market value of Predictive Oncology is measured differently than its book value, which is the value of Predictive that is recorded on the company's balance sheet. Investors also form their own opinion of Predictive Oncology's value that differs from its market value or its book value, called intrinsic value, which is Predictive Oncology's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Predictive Oncology's market value can be influenced by many factors that don't directly affect Predictive Oncology's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Predictive Oncology's value and its price as these two are different measures arrived at by different means. Investors typically determine if Predictive Oncology is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Predictive Oncology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.